drugset / Trial / NCT01812980
Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women
Phase 4
Completed
105 enrolled
University of Witwatersrand, South Africa
Bill and Melinda Gates Foundation · collab
NaSingle-groupOpen-labelBasic science
Summary
The overall aim of this project is to evaluate the immunogenicity of TIV vaccination in HIV-infected non-pregnant women in 2013. Safety data including solicited local and systemic reactions to the vaccine will also be assessed.
Timeline
- Start
- 2013-05
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Virus Vaccine | Vaccine | — | Intramuscular |